BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 1866811)

  • 1. [Atrial fibrillation--thromboembolism and prevention].
    Petersen P; Boysen G; Godtfredsen J
    Ugeskr Laeger; 1991 Jul; 153(30):2105-7. PubMed ID: 1866811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of thromboembolic events in atrial fibrillation.
    Koefoed BG; Gulløv AL; Petersen P
    Thromb Haemost; 1997 Jul; 78(1):377-81. PubMed ID: 9198182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiarrhythmic prophylaxis vs warfarin anticoagulation to prevent thromboembolic events among patients with atrial fibrillation. A decision analysis.
    Middlekauff HR; Stevenson WG; Gornbein JA
    Arch Intern Med; 1995 May; 155(9):913-20. PubMed ID: 7726699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oral anticoagulation for prevention of thromboembolism in non-rheumatic atrial fibrillation: indications, effectiveness and risk].
    Kottkamp H; Willems S; Hindricks G; Chen X; Haverkamp W; Hasfeld M; Borggrefe M; Breithardt G
    Z Kardiol; 1993 Nov; 82(11):667-73. PubMed ID: 8291287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Embolic complications of chronic atrial fibrillation].
    Koenig A; Théolade R; Chauvin M; Brechenmacher C
    Arch Mal Coeur Vaiss; 1992 Mar; 85(3):315-23. PubMed ID: 1575609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk factors for thromboembolism in patients with atrial fibrillation during treatment with aspirin: a multicenter, cooperative retrospective study. Research Group for Antiarrhythmic Drug Therapy].
    J Cardiol; 2000 May; 35(5):373-9. PubMed ID: 10834181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Atrial fibrillation and thromboembolism: a multicenter cooperative study. Research Group for Antiarrhythmic Drug Therapy].
    J Cardiol; 1998 Apr; 31(4):227-38. PubMed ID: 9594372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thromboembolic complications in atrial fibrillation.
    Petersen P
    Stroke; 1990 Jan; 21(1):4-13. PubMed ID: 2405547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of combined anticoagulant (fluindione)-aspirin therapy in patients with atrial fibrillation at high risk for thromboembolic complications. A randomized trial (FFAACS)].
    Lechat P; Lardoux H; Mallet A; Sanchez P; Derumeaux G; Lecompte T; Maillard L; Mas JL; Mentré F; Pousset F; Lacomblez L; Pisica G; Solbes-Latourette S; Raynaud P; Chaumet-Riffaud P;
    Therapie; 2000; 55(6):681-9. PubMed ID: 11234463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of thromboembolism in patients with atrial fibrillation].
    Veselka J; Bartůnĕk P
    Vnitr Lek; 1996 Nov; 42(11):792-5. PubMed ID: 9012126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Atrial fibrillation and thromboembolic events prevention. State of the art].
    Matteoli S; Trappolini M; Chillotti FM
    Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.
    Petersen P; Kastrup J; Helweg-Larsen S; Boysen G; Godtfredsen J
    Arch Intern Med; 1990 Apr; 150(4):819-21. PubMed ID: 2183733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of thromboembolism in non-rheumatic atrial fibrillation: an update].
    Pengo V; De Caterina R
    Ital Heart J Suppl; 2001 Sep; 2(9):972-9. PubMed ID: 11675834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboembolic prophylaxis in nonrheumatic atrial fibrillation: utilization patterns, efficacy, and complications in a long-term follow-up of community patients.
    Blich M; Gross B
    Int J Cardiol; 2004 Jul; 96(1):89-95. PubMed ID: 15203266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation and thromboembolic stroke.
    Aronow WS
    Compr Ther; 1994; 20(3):186-91. PubMed ID: 8187461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute management of atrial fibrillation: Part II. Prevention of thromboembolic complications.
    King DE; Dickerson LM; Sack JL
    Am Fam Physician; 2002 Jul; 66(2):261-4. PubMed ID: 12152961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term prevention of thromboembolic complications in patients with atrial fibrillation with aspirin plus clopidogrel: the Clopidogrel-Aspirin Atrial Fibrillation (CLAAF) pilot study.
    Lorenzoni R; Lazzerini G; Cocci F; De Caterina R
    Am Heart J; 2004 Jul; 148(1):e6. PubMed ID: 15215815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anticoagulation in patients with atrial fibrillation].
    Mügge A
    Herz; 1996 Feb; 21(1):28-36. PubMed ID: 8647577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of coumadin and aspirin for primary cardioembolic stroke and thromboembolic preventions of chronic rheumatic mitral stenosis with atrial fibrillation.
    Poungvarin N; Opartkiattikul N; Chaithiraphan S; Viriyavejakul A
    J Med Assoc Thai; 1994 Jan; 77(1):1-6. PubMed ID: 7798824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thromboembolic complications of arrhythmia due to atrial fibrillation].
    Lekieffre J; Lacroix D; Klug D; Kacet S
    Arch Mal Coeur Vaiss; 1994 Sep; 87 Spec No 3():17-23. PubMed ID: 7786120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.